# Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

> **NCT01414075** · PHASE2 · COMPLETED · sponsor: **Kyntra Bio** · enrollment: 60 (actual)

## Conditions studied

- Dialysis
- Anemia

## Interventions

- **DRUG:** Roxadustat
- **DRUG:** Oral Iron
- **DRUG:** IV Iron

## Key facts

- **NCT ID:** NCT01414075
- **Lead sponsor:** Kyntra Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-21
- **Primary completion:** 2013-01-10
- **Final completion:** 2013-01-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414075, "Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01414075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*